An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

Lisa, a patient living with CML, shares her experience and discusses the importance of speaking up about unmet needs in your disease.

The disease hobbles families and economies.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.